VCEL Vericel Corporation

Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences First Quarter Fiscal Year End 2006 Investor Conference Call When: Wednesday, November 9, 2005 @ 11:00 AM Eastern Where: http://www.investorcalendar.com/IC/CEPage.asp?ID=96864 How: -- For live over the Internet access, simply log on to the web at the address above. -- For phone access, interested parties should call toll-free (877) 407-9205 before the start of the call to register and identify themselves as registrants of the "Aastrom Conference Call". Any registered caller on the toll-free line may ask for call operator for directions to be placed in the queue for the Question & Answer session. -- To download the podcast, simply log on to the web at the address above. If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ for 60 days. Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing patient-specific products for the repair or regeneration of human tissues, utilizing the Company's proprietary adult stem cell technology. Aastrom's strategic position in the tissue regeneration sector is enabled by its proprietary Tissue Repair Cells (TRCs), a mix of bone marrow-derived adult stem and progenitor cells manufactured in the AastromReplicell(R) System, an industry-unique automated cell production system. TRCs are the core component of the products Aastrom is developing for severe bone fractures, ischemic vascular disease, jaw reconstruction and spine fusion, with Phase I/II level clinical trials active in the U.S. and EU for some of these indications. For more information, visit Aastrom's website at www.aastrom.com.